Results 301 to 310 of about 26,112,494 (338)

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Iain B Mcinnes, Philip J Mease, Bruce W Kirkham   +2 more
exaly  

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.

Journal of the American Medical Association (JAMA), 1994
S. Rosenberg, J. Yang, S. Topalian, D. Schwartzentruber, J. Weber, D. Parkinson, C. Seipp, J. Einhorn, D. White   +8 more
semanticscholar   +1 more source

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Lancet, The, 2017
B G Feagan, Julian Panes, Arthur Kaser
exaly  

Interleukin-2☆

2004
openaire   +1 more source

[Interleukin 2 and interleukin 2 receptors].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1991
S, Minamoto, T, Taniguchi
openaire   +1 more source

Interleukin 2 see Interferon gamma/interleukin 2

Reactions Weekly, 1991
openaire   +1 more source

Interleukin 2

2014
Arenas-Ramirez, Natalia, Boyman, Onur
openaire   +1 more source

Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

European Journal of Immunology, 1988
H. Karasuyama, F. Melchers
semanticscholar   +1 more source

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, John Gregson, Peter Willeit   +2 more
exaly  

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature Reviews Drug Discovery, 2012
Charles A Dinarello, Anna Simon, Jos W M Van Der Meer   +2 more
exaly